Clinical Trial Update: A Long Term Roll-over Study to Investigate the Efficacy and Safety of Adalimumab Given Long-term to Patients With Rheumatoid Arthritis [Phase 3]

View source ↗

Summary

A long-term extension study of adalimumab in rheumatoid arthritis has completed, assessing efficacy and safety of extended treatment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Humira (adalimumab)

Snippet

Sponsor: Abbott | Conditions: Rheumatoid Arthritis | Phase 3 | Status: COMPLETED